Understanding Nonadherence to Antihypertensive Medications: Patterns, Predictors, Barriers, and Access challenges in a Tertiary Care Setting in Libya

Authors

DOI:

https://doi.org/10.69667/lmj.2517324

Keywords:

Medication Adherence, Compliance, Concordance, Hypertension, Antihypertensive Agents.

Abstract

Adherence to medications is crucial to achieving optimal control in chronic diseases, including hypertension. This study describes the characteristics of adherent and non-adherent patients on antihypertensive medication in a tertiary care setting in Libya. It further examines the subtypes of non-adherence, the perceived barriers related to each subtype, the key predictors of non-adherence, and reports medication access difficulties faced by all patients regardless of their adherence. The study utilized data from a larger cross-sectional study in one of the largest tertiary hospitals in Libya. The cohort for this analysis consisted of 320 antihypertensive patients who had been on antihypertensive agents for more than 6 months. Data were obtained using structured interviews and medical records. The mean age of this cohort was 54.32 years (SD=10.39), and 60.3% were females. The prevalence of medication nonadherence was 34.9%. The most common subtype was unintentional non-adherence, accounting for 66.7% of non-adherents. Among the unintentional barriers, forgetfulness (55.0%) was the most frequently reported, whereas feeling well (21.6%) was the most prevalent intentional barrier. Overall, 68.5% of patients reported experiencing problems in accessing their medications, irrespective of their adherence status, with the majority reporting high cost as the main problem (93.1%). Predictors of medication nonadherence were irregular follow-up (P <0.001, OR=3.540, 95% CI: 1.982- 6.326), and no Home Monitoring of Blood Pressure (HMBP) (P = 0.006, OR=2.326, 95% CI: 1.275-4.244). In conclusion, medication non-adherence, predominantly the unintentional subtype, is considerable among hypertensive patients, with forgetfulness and feeling well-being the most prevalent barriers. Educational interventions about the importance of regular follow-up and HMBP, improving access to affordable medications, may improve medication adherence.

References

Achterbosch M, Aksoy N, Obeng GD, Ameyaw D, Ágh T, Van Boven JF. Clinical and economic consequences of medication nonadherence: a review of systematic reviews. Front Pharmacol. 2025 Jun 25;16:1570359.

Algabbani FM, Algabbani AM. Treatment adherence among patients with hypertension: findings from a cross-sectional study. Clin Hypertens. 2020 Sep 15;26(1):18.

Al Ghobain M, Alhashemi H, Aljama A, Bin Salih S, Assiri Z, Alsomali A, Mohamed G. Nonadherence to antihypertensive medications and associated factors in general medicine clinics. Patient Prefer Adherence. 2016 Aug 1;10:1415-1419.

Al-Qasem A, Smith F, Clifford S. Adherence to medication among chronic patients in Middle Eastern countries: review of studies. East Mediterr Health J. 2011 Apr 1;17(4):356-363.

Ashur ST, Shah SA, Bosseri S, Morisky DE, Shamsuddin K. Illness perceptions of Libyans with T2DM and their influence on medication adherence: a study in a diabetes center in Tripoli. Libyan J Med. 2015;10(1):29792.

Atair A, Mohamed M, Bashir S, Edress N, Younis Z. Factors Associated with Non -Adherence to Antidiabetic Medications among Patients with Type 2 DM in Al-Bayda- Libya. Alq J Med App Sci. 2023;6(1):193-200.

Bader RJ, Koprulu F, Hassan NA, Ali AA, Elnour AA. Predictors of adherence to antihypertensive medication in northern United Arab Emirates. East Mediterr Health J. 2015 May 1;21(5):309-318.

Belayachi S, Boukhari FZ, Essayagh F, Terkiba O, Zohoun A, Essayagh M, Essayagh T, Essayagh S. Non-adherence to antihypertensive drugs and its risk factors among hypertensive patients, Marrakech, Morocco. PLOS Glob Public Health. 2024 Aug 27;4(8):e0002774.

Bhandari B, Bhattarai M, Bhandari M, Ghimire A, Pokharel P, Morisky D. Adherence to antihypertensive medications: population based follow up in Eastern Nepal. J Nepal Health Res Counc. 2015;13(29):38-42.

Brookhart MA, Patrick AR, Schneeweiss S, Avorn J, Dormuth C, Shrank W, Van Wijk BL, Cadarette SM, Canning CF, Solomon DH. Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use. Arch Intern Med. 2007 Apr 23;167(8):847-852.

Chan YH. Biostatistics 202: logistic regression analysis. Singapore Med J. 2004 Apr;45(4):149-153.

Cochran WG. Sampling techniques. 3rd ed. John Wiley & Sons; 1977.

Cook CL, Perri M 3rd. Single-item vs multiple-item measures of stage of change in compliance with prescribed medications. Psychol Rep. 2004 Feb;94(1):115-124.

Cordova-Ruiz GL, Fernández-Rodríguez LJ, Bardales-Zuta VH. Sociodemographic factors associated with medication adherence among hypertensive patients in northern Peru: a cross-sectional study. Arch Cardiol Mex. 2025 Sep;95(3):153-159.

Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018 Jan 1;8(1):e016982.

Du L, Cheng Z, Zhang Y, Li Y, Mei D. The impact of medication adherence on clinical outcomes of coronary artery disease: A meta-analysis. Eur J Prev Cardiol. 2017 Jun 1;24(9):962-970.

Elmu zghi RF. Assessing the influential factors associated with medication non-adherence and self-care practices among type 2 diabetes mellitus patients in Tripoli, Libya. Sci Pharm. 2023 Jun 19;2(2):104-116.

Fadel RB, Ashur ST. Predictors of Uncontrolled Hypertension Among Libyan Patients: A Cross-Sectional Study at Tripoli University Hospital. AlQalam J Med Appl Sci. 2025 Sep 2:1879-1889.

Fierro-Carrion GA, Ram CV. Nonsteroidal anti-inflammatory drugs (NSAIDs) and blood pressure. Am J Cardiol. 1997 Sep 15;80(6):775-776.

Fragoulis C, Prentakis AG, Kontogianni E, Polyzos D, Tsioufis PA, Fragouli D, Leontsinis I, Mantzouranis E, Sakalidis A, Mavroudis A, Kalos T, Chrysochoou C, Politis A, Tsioufis KP. Medication adherence in relation with physical activity in hypertensive patients: data from a behavioral cardiology unit. Eur J Prev Cardiol. 2023 Jun;30(Suppl 1):zwad125.132.

Ibrahim S, Nurmohamed NS, Collard D, Weger AD, Reeskamp R, Hovingh GK, Stroes ES, Brouwer T. One-item adherence questionnaire correlates with on-treatment blood pressure and ldl cholesterol levels in high risk hypertensive patients over time. J Am Coll Cardiol. 2023 Mar 7;81(8_Supplement):1828.

Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med. 1994 Aug 15;121(4):289-300.

Kengne AP, Brière JB, Zhu L, Li J, Bhatia MK, Atanasov P, Khan ZM. Impact of poor medication adherence on clinical outcomes and health resource utilization in patients with hypertension and/or dyslipidemia: systematic review. Expert Rev Pharmacoecon Outcomes Res. 2024 Jan 2;24(1):143-154.

Khadoura K, Shakibazadeh E, Mansournia MA, Aljeesh Y, Fotouhi A. Determining the prevalence of and the factors associated with antihypertensive medication non-adherence in the Gaza Strip. Korean J Fam Med. 2020 Mar 2;42(2):150-156.

Lee EK, Poon P, Yip BH, Bo Y, Zhu MT, Yu CP, Ngai AC, Wong MC, Wong SY. Global burden, regional differences, trends, and health consequences of medication nonadherence for hypertension during 2010 to 2020: a meta‐analysis involving 27 million patients. J Am Heart Assoc. 2022 Sep 6;11(17):e026582.

Macalinao D, Marcos JA, Francisco PJ. Antihypertensive Medications Adherence and Its Relationship to Blood Pressure Control Among Healthcare Workers in Jose R. Reyes Memorial Medical Center (JRRMMC): A Retrospective Analytic Study. [Unpublished or from a source not indexed in MEDLINE].

MacIntyre IM, Turtle EJ, Farrah TE, Graham C, Dear JW, Webb DJ. Regular acetaminophen use and blood pressure in people with hypertension: the PATH-BP trial. Circulation. 2022 Feb 8;145(6):416-423.

Mahmood S, Jalal Z, Hadi MA, Orooj H, Shah KU. Non-adherence to prescribed antihypertensives in primary, secondary and tertiary healthcare settings in Islamabad, Pakistan: a cross-sectional study. Patient Prefer Adherence. 2020 Jan 14;14:73-85.

Nikolic A, Djuric S, Biocanin V, Djordjevic K, Ravic M, Stojanovic A, Milovanovic O, Skerlic J, Pavlovic R, Turnic TN. Predictors of non-adherence to medications in hypertensive patients. Iran J Public Health. 2023 Jun;52(6):1181-1191.

Oyan B, Abere S, Ajala AO, Okeke UF, Briggs FK, Chris-Biriowu H. Sociodemographic and clinical determinants of adherence to blood pressure medication in hypertensive subjects. Afr J Res Med Health Sci. 2024;2(2).

Religioni U, Barrios-Rodríguez R, Requena P, Borowska M, Ostrowski J. Enhancing therapy adherence: impact on clinical outcomes, healthcare costs, and patient quality of life. Medicina (Kaunas). 2025 Jan 17;61(1):153.

Sabaté E, editor. Adherence to long-term therapies: evidence for action. World Health Organization; 2003.

Salama L, Al-Maedani A, Bengharbia M, Aljafil H. Prevalence and Predictors of Polypharmacy and Medication Adherence among Elderly Patients in Benghazi-Libya. Benghazi Univ Med J. 2025 Jul 10;2(1):108-131.

Souza AC, Borges JW, Moreira TM. Quality of life and treatment adherence in hypertensive patients: systematic review with meta-analysis. Rev Saude Publica. 2016;50:71.

Spence JD, Grosser T, FitzGerald GA. Acetaminophen, nonsteroidal anti-inflammatory drugs, and hypertension. Hypertension. 2022 Sep;79(9):1922-1926.

Trefond J, Hermet L, Lambert C, Vaillant-Roussel H, Pouchain D, Ménini T, Pereira B, Vorilhon P. Home blood pressure monitoring and adherence in patients with hypertension on primary prevention treatment: a survey of 1026 patients in general medicine in the Auvergne region. BMC Prim Care. 2022 May 26;23(1):131.

Turki F, Turki I, Jedidi J, Said H. Medication Adherence, Blood Pressure Control, Knowledge, Self-care and Self-efficacy among Tunisian Hypertensive Patients. Open Nurs J. 2024 Oct 23;18(1).

Wong WJ, Nguyen TV, Nguyen VT, Ngo KT, Nguyen TN. Forgetfulness to take antihypertensive medications and poor blood pressure control in older adults with type 2 diabetes and hypertension in Vietnam. J Clin Hypertens (Greenwich). 2025 Aug;27(8):e70105.

Wu JR, DeWalt DA, Baker DW, Schillinger D, Ruo B, Bibbins‐Domingo K, Macabasco‐O'Connell A, Holmes GM, Broucksou KA, Erman B, Hawk V. A single‐item self‐report medication adherence question predicts hospitalisation and death in patients with heart failure. J Clin Nurs. 2014 Sep;23(17-18):2554-2564

Downloads

Published

2025-09-13

How to Cite

Sana Taher Ashur, & Rida Ben Fadel. (2025). Understanding Nonadherence to Antihypertensive Medications: Patterns, Predictors, Barriers, and Access challenges in a Tertiary Care Setting in Libya. Libyan Medical Journal, 488–495. https://doi.org/10.69667/lmj.2517324

Issue

Section

Articles

Categories